Literature DB >> 34926077

Pursuing Investigations Establish the Challenging Diagnosis of Primary Aldosteronism.

Than Aung1, Haresh Tulsidas1.   

Abstract

Primary aldosteronism is one of the causes of secondary hypertension. The most sensitive screening test for primary aldosteronism is the measurement of the plasma aldosterone concentration and plasma renin activity to calculate the aldosterone/renin ratio. We report a case of hypertension and hypokalemia with a negative plasma aldosterone/renin ratio, inconclusive confirmatory saline infusion test. Subsequently, the patient was diagnosed with primary aldosteronism secondary to adrenal adenoma. If there is a high index of clinical suspicion of primary aldosteronism, it is important to evaluate further to establish the diagnosis for initiation of specific treatment because failure to identify primary aldosteronism can lead to aldosterone-specific adverse cardiovascular diseases and events.
Copyright © 2021, Aung et al.

Entities:  

Keywords:  adrenal adenoma; aldosterone renin ratio; hypokalemia; primary aldosteronism; secondary hypertension

Year:  2021        PMID: 34926077      PMCID: PMC8673692          DOI: 10.7759/cureus.19613

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

1.  Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study.

Authors:  Ying Song; Shumin Yang; Wenwen He; Jinbo Hu; Qingfeng Cheng; Yue Wang; Ting Luo; Linqiang Ma; Qianna Zhen; Suhua Zhang; Mei Mei; Zhihong Wang; Hua Qing; Dennis Bruemmer; Bin Peng; Qifu Li
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

2.  Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism.

Authors:  Annie Hung; Sumaiya Ahmed; Ankur Gupta; Alexandra Davis; Gregory A Kline; Alexander A Leung; Marcel Ruzicka; Swapnil Hiremath; Gregory L Hundemer
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

3.  Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.

Authors:  Cristiana Catena; GianLuca Colussi; Roberta Lapenna; Elisa Nadalini; Alessandra Chiuch; Pasquale Gianfagna; Leonardo A Sechi
Journal:  Hypertension       Date:  2007-09-24       Impact factor: 10.190

4.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

5.  The diagnosis of primary aldosteronism and separation of two major subtypes.

Authors:  M H Weinberger; N S Fineberg
Journal:  Arch Intern Med       Date:  1993-09-27

6.  Investigating hypokalaemia.

Authors:  Richard A Oram; Timothy J McDonald; Bijay Vaidya
Journal:  BMJ       Date:  2013-09-24

7.  The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.

Authors:  Jenifer M Brown; Mohammed Siddiqui; David A Calhoun; Robert M Carey; Paul N Hopkins; Gordon H Williams; Anand Vaidya
Journal:  Ann Intern Med       Date:  2020-05-26       Impact factor: 25.391

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.